Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 147 papers

Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: A multicenter analysis

Karvellas CJ, Garcia-Lopez E, Fernandez J, Saliba F, Sy E, Jalan R, Pavesi M, Gustot T, Ronco JJ, Arroyo V; Chronic Liver Failure Consortium and European Foundation for the Study of Chronic Liver Failure

Crit Care Med 2018, 46(11): 1783–1791

DOI: 10.1097/CCM.0000000000003369

Oxidized albumin triggers a cytokine storm in leukocytes through p38 mitogen-activated protein kinase: Role in systemic inflammation in decompensated cirrhosis

Alcaraz-Quiles J, Casulleras M, Oettl K, Titos E, Flores-Costa R, Duran-Güell M, López-Vicario C, Pavesi M, Stauber RE, Arroyo V, Clària J.

Hepatology 2018, 68(5): 1937–1952

DOI: 10.1002/hep.30135

Bacterial and fungal infections in acute-on-chronic liver failure: Prevalence, characteristics and impact on prognosis

Fernández J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, Reverter E, Martínez J, Saliba F, Jalan R, Welzel T, Pavesi M, Hernández-Tejero M, Ginès P, Arroyo V; European Foundation for the Study of Chronic Liver Failure.

Gut 2018, 67(10): 1870–1880

DOI: 10.1136/gutjnl-2017-314240

Closed-loop lumped parameter modeling of hemodynamics during cirrhogenesis in rats

Audebert C, Peeters G, Segers P, Laleman W, Monbaliu D, Korf H, Trebicka J, Vignon-Clementel IE, Debbaut C

IEEE Trans Biomed Eng 2018, 65(10): 2311–2322

DOI: 10.1109/TBME.2018.2793948

Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: Preclinical results

Luetkens JA, Klein S, Träber F, Schmeel FC, Sprinkart AM, Kuetting DLR, Block W, Uschner FE, Schierwagen R, Hittatiya K, Kristiansen G, Gieseke J, Schild HH, Trebicka J, Kukuk GM.

Radiology 2018, 288(3): 748–754

DOI: 10.1148/radiol.2018180051

The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis

Sersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, Putignano A, Weichselbaum L, Deltenre P, Degré D, Trépo E, Moreno C, Gustot T.

J Hepatol 2018, 69(2): 318–324

DOI: 10.1016/j.jhep.2018.02.022

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.

Sci Rep 2018, 8(1): 9372

DOI: 10.1038/s41598-018-27656-y

The use of human albumin in patients with cirrhosis: A European survey

Caraceni P, Pavesi M, Baldassarre M, Bernardi M, Arroyo V.

Expert Rev Gastroenterol Hepatol 2018, 12(6): 625–632

DOI: 10.1080/17474124.2018.1460203

Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis

Simón-Talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-Martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J; Baveno VI-SPSS group from the Baveno Cooperation

Gastroenterology 2018, 154(6): 1694–1705.e4

DOI: 10.1053/j.gastro.2018.01.028

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis

Ruiz-Margáin A, Pohlmann A, Ryan P, Schierwagen R, Chi-Cervera LA, Jansen C, Mendez-Guerrero O, Flores-García NC, Lehmann J, Torre A, Macías-Rodríguez RU, Trebicka J.

Liver Transpl 2018, 24(5): 595–605

DOI: 10.1002/lt.25041